Twist Bioscience Q3 2021 Earnings Report

Reported revenue growth of 65% and gross margin of 40%.

Key Takeaways

Twist Bioscience reported strong financial results for the third quarter of fiscal year 2021, with revenue growth of 65% year-over-year and a gross margin of 40%. The company raised its revenue guidance based on continued strength across its business.

Revenue growth of 65% over fiscal 2020 third quarter.

Order growth of 58% year over year.

Gross margin of 40% for the quarter.

Raised revenue guidance based on continued strength across the business

Total Revenue

$35M

Previous year: $21.2M

+65.1%

EPS

-$0.78

Previous year: -$0.67

+16.4%